Corcept Therapeutics (CORT) announced that the FDA has issued a complete response letter, or CRL, regarding the new drug application, or NDA, for relacorilant as a treatment for patients with ...
For the first time, researchers have managed to isolate and directly observe individual oxygen atoms inside liquid water, ...
Beauty lovers have been heavy-handed with their blush for the last two years, but these rosy pigments will be utilized in a ...